An analysis of 25 years of the CDC WONDER database for death rates from hypertension-related kidney disease (also called hypertensive kidney disease or hypertensive renal disease) in the U.S. through ...

Mortality from hypertensive kidney disease in the U.S. has grown by 48%, according to an abstract presented Sept. 5 at the American Heart Association’s 2025 Hypertension Scientific Sessions.

The United States death rate from high blood pressure-related kidney disease experienced a 48% jump over the last 25 years, according to preliminary research presented at the American Heart ...

The investigational aldosterone synthase inhibitor lorundrostat demonstrated efficacy in reducing systolic blood pressure and ...

Poor hypertensive medication adherence was associated with unmet social needs. Young adults with youth-onset type 2 diabetes and hypertension, dyslipidemia, or nephropathy poorly adhere to ...

Hypertension contributes to the development and progression of chronic complications of diabetes. In patients with type 1 diabetes, persistent hypertension is often a manifestation of diabetic ...

Preeclampsia is an important risk factor for chronic kidney disease and warrants post-delivery monitoring, according to investigators. Pregnant women with preeclampsia are at increased risk for ...

Novo Nordisk has again turned to dealmaking to expand its pipeline, but rather than adding yet another weight loss drug prospect the company is acquiring a molecule that’s a potential treatment for ...

The death rate from hypertensive kidney disease (high blood pressure-related kidney disease) increased by 48% in the U.S. over the past 25 years, with continued differences across demographic groups, ...